CaPSURE

CaPSURE™ is a longitudinal, observational study of approximately 15,000 men with all stages of biopsy-proven prostate cancer. Patients have enrolled at 43 community urology practices, academic medical centers, and VA hospitals throughout the United States since 1995. CEASAR stands for Comparative Effectiveness Analysis of Surgery and Radiation. The ongoing goal of CEASAR is to help learn more about what prostate cancer treatments work best, for which patients, in whose hands. There are currently about 3,600 men with a prostate cancer diagnosis participating in CEASAR. Three rounds of surveys have been completed, with the first carried out in the spring of 2010. We are currently in the process of conducting our fourth survey with the same group of men in our study. This survey, our Three Year Follow-up, will occur throughout the summer of 2014.

CaPSURE™是一项针对约15,000名处于不同病理阶段的经活检证实患有前列腺癌的男性的纵向观察性研究。自1995年以来，患者已在美国43家社区泌尿科诊所、学术医学中心和退伍军人医院登记入组。CEASAR代表手术与放射治疗的比较有效性分析。CEASAR的持续目标是深入了解哪些前列腺癌治疗方案最为有效，适用于哪些患者，以及由哪些医疗专家施行。目前，约有3,600名患有前列腺癌的男性正在参与CEASAR项目。已完成三轮调查，其中首轮调查于2010年春季进行。我们目前正在对同一组男性进行第四次调查，即我们的三年随访调查，该调查将在2014年夏季进行。